• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用初级保健中常规测量的预后预测因子预测 COPD1 年死亡率。

Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care.

机构信息

National Heart Lung Institute, Imperial College London, Emmanuel Kaye Building, 1b Manresa Road, London, SW3 6LR, UK.

Department of Statistical Science, University College London, London, UK.

出版信息

BMC Med. 2019 Apr 5;17(1):73. doi: 10.1186/s12916-019-1310-0.

DOI:10.1186/s12916-019-1310-0
PMID:30947728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6449897/
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is a major cause of mortality. Patients with advanced disease often have a poor quality of life, such that guidelines recommend providing palliative care in their last year of life. Uptake and use of palliative care in advanced COPD is low; difficulty in predicting 1-year mortality is thought to be a major contributing factor.

METHODS

We identified two primary care COPD cohorts using UK electronic healthcare records (Clinical Practice Research Datalink). The first cohort was randomised equally into training and test sets. An external dataset was drawn from a second cohort. A risk model to predict mortality within 12 months was derived from the training set using backwards elimination Cox regression. The model was given the acronym BARC based on putative prognostic factors including body mass index and blood results (B), age (A), respiratory variables (airflow obstruction, exacerbations, smoking) (R) and comorbidities (C). The BARC index predictive performance was validated in the test set and external dataset by assessing calibration and discrimination. The observed and expected probabilities of death were assessed for increasing quartiles of mortality risk (very low risk, low risk, moderate risk, high risk). The BARC index was compared to the established index scores body mass index, obstructive, dyspnoea and exacerbations (BODEx), dyspnoea, obstruction, smoking and exacerbations (DOSE) and age, dyspnoea and obstruction (ADO).

RESULTS

Fifty-four thousand nine hundred ninety patients were eligible from the first cohort and 4931 from the second cohort. Eighteen variables were included in the BARC, including age, airflow obstruction, body mass index, smoking, exacerbations and comorbidities. The risk model had acceptable predictive performance (test set: C-index = 0.79, 95% CI 0.78-0.81, D-statistic = 1.87, 95% CI 1.77-1.96, calibration slope = 0.95, 95% CI 0.9-0.99; external dataset: C-index = 0.67, 95% CI 0.65-0.7, D-statistic = 0.98, 95% CI 0.8-1.2, calibration slope = 0.54, 95% CI 0.45-0.64) and acceptable accuracy predicting the probability of death (probability of death in 1 year, n high-risk group, test set: expected = 0.31, observed = 0.30; external dataset: expected = 0.22, observed = 0.27). The BARC compared favourably to existing index scores that can also be applied without specialist respiratory variables (area under the curve: BARC = 0.78, 95% CI 0.76-0.79; BODEx = 0.48, 95% CI 0.45-0.51; DOSE = 0.60, 95% CI 0.57-0.61; ADO = 0.68, 95% CI 0.66-0.69, external dataset: BARC = 0.70, 95% CI 0.67-0.72; BODEx = 0.41, 95% CI 0.38-0.45; DOSE = 0.52, 95% CI 0.49-0.55; ADO = 0.57, 95% CI 0.54-0.60).

CONCLUSION

The BARC index performed better than existing tools in predicting 1-year mortality. Critically, the risk score only requires routinely collected non-specialist information which, therefore, could help identify patients seen in primary care that may benefit from palliative care.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b28c/6449897/017209cf5698/12916_2019_1310_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b28c/6449897/6074d67b6c8f/12916_2019_1310_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b28c/6449897/017209cf5698/12916_2019_1310_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b28c/6449897/6074d67b6c8f/12916_2019_1310_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b28c/6449897/017209cf5698/12916_2019_1310_Fig2_HTML.jpg
摘要

背景

慢性阻塞性肺疾病(COPD)是主要的死亡原因之一。晚期疾病患者的生活质量往往较差,因此指南建议在生命的最后一年提供姑息治疗。晚期 COPD 患者接受姑息治疗的比例和使用率均较低;难以预测 1 年死亡率被认为是主要的促成因素。

方法

我们使用英国电子医疗记录(临床实践研究数据链接)识别了两个初级保健 COPD 队列。第一个队列被平均分为训练集和测试集。第二个队列的数据取自外部数据集。使用向后消除 Cox 回归从训练集中推导出预测 12 个月内死亡率的风险模型。该模型基于可能的预后因素(包括体重指数和血液结果(B)、年龄(A)、呼吸变量(气流阻塞、加重、吸烟)(R)和合并症(C))的缩写为 BARC。在测试集和外部数据集中验证了 BARC 指数的预测性能,通过评估校准和区分来评估。评估了死亡风险增加的四个四分位数(极低风险、低风险、中风险、高风险)的观察到的和预期的死亡概率。将 BARC 指数与已建立的指数评分(体重指数、阻塞、呼吸困难和加重(BODEx)、呼吸困难、阻塞、吸烟和加重(DOSE)和年龄、呼吸困难和阻塞(ADO))进行了比较。

结果

从第一个队列中选出了 54990 名符合条件的患者,从第二个队列中选出了 4931 名患者。BARC 中包含了 18 个变量,包括年龄、气流阻塞、体重指数、吸烟、加重和合并症。风险模型具有可接受的预测性能(测试集:C 指数=0.79,95%CI 0.78-0.81,D 统计量=1.87,95%CI 1.77-1.96,校准斜率=0.95,95%CI 0.9-0.99;外部数据集:C 指数=0.67,95%CI 0.65-0.7,D 统计量=0.98,95%CI 0.8-1.2,校准斜率=0.54,95%CI 0.45-0.64)和可接受的预测死亡概率的准确性(1 年的死亡概率,高风险组的 n,测试集:预期=0.31,观察=0.30;外部数据集:预期=0.22,观察=0.27)。BARC 与其他现有的指数评分相比表现良好,这些评分也可以在没有专门的呼吸变量的情况下应用(曲线下面积:BARC=0.78,95%CI 0.76-0.79;BODEx=0.48,95%CI 0.45-0.51;DOSE=0.60,95%CI 0.57-0.61;ADO=0.68,95%CI 0.66-0.69,外部数据集:BARC=0.70,95%CI 0.67-0.72;BODEx=0.41,95%CI 0.38-0.45;DOSE=0.52,95%CI 0.49-0.55;ADO=0.57,95%CI 0.54-0.60)。

结论

BARC 指数在预测 1 年死亡率方面优于现有的工具。至关重要的是,风险评分只需要常规收集非专业信息,因此,这可能有助于识别在初级保健中接受姑息治疗的患者。

相似文献

1
Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care.使用初级保健中常规测量的预后预测因子预测 COPD1 年死亡率。
BMC Med. 2019 Apr 5;17(1):73. doi: 10.1186/s12916-019-1310-0.
2
External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.使用标准和机器学习方法在初级保健 COPD 患者中预测死亡的 ADO、DOSE、COTE 和 CODEX 的外部验证。
Respir Med. 2018 May;138:150-155. doi: 10.1016/j.rmed.2018.04.003. Epub 2018 Apr 12.
3
External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort.来自伯明翰慢性阻塞性肺疾病队列研究中慢性阻塞性肺疾病患者更新版ADO评分的外部验证
Int J Chron Obstruct Pulmon Dis. 2019 Oct 24;14:2395-2407. doi: 10.2147/COPD.S212381. eCollection 2019.
4
Discriminative and predictive properties of multidimensional prognostic indices of chronic obstructive pulmonary disease: a validation study in Taiwanese patients.慢性阻塞性肺疾病多维预后指数的判别和预测特性:一项针对台湾患者的验证研究。
Respirology. 2014 Jul;19(5):694-9. doi: 10.1111/resp.12313. Epub 2014 May 6.
5
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.慢性阻塞性肺疾病患者预后评估的扩展:更新后的BODE指数和ADO指数。
Lancet. 2009 Aug 29;374(9691):704-11. doi: 10.1016/S0140-6736(09)61301-5.
6
Prognostic assessment in COPD without lung function: the B-AE-D indices.慢性阻塞性肺疾病(COPD)无肺功能情况下的预后评估:B-AE-D指数
Eur Respir J. 2016 Jun;47(6):1635-44. doi: 10.1183/13993003.01485-2015. Epub 2016 Apr 21.
7
External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort).在一个初级保健国际队列(PROEPOC/COPD队列)中对多维预后指数(ADO、BODEx和DOSE)进行外部验证。
BMC Pulm Med. 2016 Nov 11;16(1):143. doi: 10.1186/s12890-016-0305-2.
8
Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.慢性阻塞性肺疾病全球倡议2013分类与体重指数、气流阻塞、呼吸困难和加重指数在预测老年慢性阻塞性肺疾病患者死亡率和病情加重方面的比较
J Am Geriatr Soc. 2015 Feb;63(2):244-50. doi: 10.1111/jgs.13258. Epub 2015 Feb 2.
9
Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.多组分评估慢性阻塞性肺疾病:对 ADO 和 DOSE 指数以及国际初级保健数据集全球阻塞性肺病分类的评估。
NPJ Prim Care Respir Med. 2016 Apr 7;26:16010. doi: 10.1038/npjpcrm.2016.10.
10
Multicomponent indices to predict survival in COPD: the COCOMICS study.多组分指数预测 COPD 患者生存:COCOMICS 研究。
Eur Respir J. 2013 Aug;42(2):323-32. doi: 10.1183/09031936.00121012. Epub 2012 Dec 6.

引用本文的文献

1
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.慢性阻塞性肺疾病与英国心肺风险的管理:一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
2
Planning Ahead: protocol for a randomised trial of advance care planning for community dwelling older adults at increased mortality risk.提前规划:针对社区居住的、死亡风险增加的老年人进行预先护理规划随机试验的方案
BMJ Open. 2025 May 24;15(5):e102186. doi: 10.1136/bmjopen-2025-102186.
3
Development and validation a nomogram to predict long-term mortality risks of PRISm and mild-to-moderate COPD based on NHANES 2007-2012.

本文引用的文献

1
Changing causes of death for patients with chronic respiratory disease in England, 2005-2015.2005-2015 年英格兰慢性呼吸道疾病患者死因变化。
Thorax. 2019 May;74(5):483-491. doi: 10.1136/thoraxjnl-2018-212514. Epub 2019 Jan 29.
2
End-of-Life Strategies among Patients with Advanced Chronic Obstructive Pulmonary Disease.晚期慢性阻塞性肺疾病患者的临终策略。
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1389-1396. doi: 10.1164/rccm.201803-0592OC.
3
External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.
基于2007 - 2012年美国国家健康与营养检查调查(NHANES)开发并验证一种列线图,以预测PRISm和轻至中度慢性阻塞性肺疾病(COPD)的长期死亡风险。
Sci Rep. 2025 May 8;15(1):16000. doi: 10.1038/s41598-025-94399-y.
4
Photoreceptor metabolic window unveils eye-body interactions.光感受器代谢窗口揭示眼-身相互作用。
Nat Commun. 2025 Jan 15;16(1):697. doi: 10.1038/s41467-024-55035-x.
5
The DOSE index in chronic obstructive pulmonary disease: evaluating healthcare costs.慢性阻塞性肺疾病中的 DOSE 指数:评估医疗保健成本。
BMC Pulm Med. 2024 Nov 8;24(1):560. doi: 10.1186/s12890-024-03368-0.
6
Prognostic models and factors identifying end-of-life in non-cancer chronic diseases: a systematic review.非癌症慢性疾病中识别临终状态的预后模型及因素:一项系统综述
BMJ Support Palliat Care. 2024 Dec 19;14(e3):e2316-e2329. doi: 10.1136/spcare-2023-004656.
7
Long-Term Mortality following Acute Noninvasive Ventilation for Obesity-Related Respiratory Failure: A Retrospective Single-Centre Study.肥胖相关性呼吸衰竭行急性无创通气治疗后的长期死亡率:一项回顾性单中心研究。
Can Respir J. 2023 Oct 12;2023:5370197. doi: 10.1155/2023/5370197. eCollection 2023.
8
Digital health in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的数字健康
Chronic Dis Transl Med. 2023 Jun 2;9(2):90-103. doi: 10.1002/cdt3.68. eCollection 2023 Jun.
9
PUMA screening tool to detect COPD in high-risk patients in Chinese primary care-A validation study.PUMA 筛查工具在中国基层医疗中用于检测 COPD 高危患者的验证研究。
PLoS One. 2022 Sep 9;17(9):e0274106. doi: 10.1371/journal.pone.0274106. eCollection 2022.
10
Physicians' Conceptions of the Dying Patient: Scoping Review and Qualitative Content Analysis of the United Kingdom Medical Literature.医生对临终患者的观念:英国医学文献的范围综述和定性内容分析。
Qual Health Res. 2022 Oct;32(12):1881-1896. doi: 10.1177/10497323221119939. Epub 2022 Aug 18.
使用标准和机器学习方法在初级保健 COPD 患者中预测死亡的 ADO、DOSE、COTE 和 CODEX 的外部验证。
Respir Med. 2018 May;138:150-155. doi: 10.1016/j.rmed.2018.04.003. Epub 2018 Apr 12.
4
Low uptake of palliative care for COPD patients within primary care in the UK.在英国,初级保健中 COPD 患者接受姑息治疗的比例较低。
Eur Respir J. 2018 Feb 14;51(2). doi: 10.1183/13993003.01879-2017. Print 2018 Feb.
5
Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的姑息治疗和麻烦症状的处理。
Lancet. 2017 Sep 2;390(10098):988-1002. doi: 10.1016/S0140-6736(17)32127-X.
6
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.全球、地区和国家慢性阻塞性肺疾病和哮喘的死亡、患病率、残疾调整生命年以及与残疾相关的生命年,1990-2015 年:2015 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16.
7
Prognostic variables and scores identifying the end of life in COPD: a systematic review.识别慢性阻塞性肺疾病终末期的预后变量和评分:一项系统评价
Int J Chron Obstruct Pulmon Dis. 2017 Jul 31;12:2239-2256. doi: 10.2147/COPD.S137868. eCollection 2017.
8
Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records.英国电子医疗记录中慢性阻塞性肺疾病急性加重住院情况的记录。
Clin Epidemiol. 2016 Nov 21;8:771-782. doi: 10.2147/CLEP.S117867. eCollection 2016.
9
Trends in the epidemiology of cardiovascular disease in the UK.英国心血管疾病流行病学趋势
Heart. 2016 Dec 15;102(24):1945-1952. doi: 10.1136/heartjnl-2016-309573. Epub 2016 Aug 22.
10
Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records.英国初级医疗电子健康记录中慢性阻塞性肺疾病急性加重记录的验证
PLoS One. 2016 Mar 9;11(3):e0151357. doi: 10.1371/journal.pone.0151357. eCollection 2016.